Palatin Gets US Patent to Use Melanocortin Peptides to Treat Immune System Dysregulation
Palatin Gets US Patent to Use Melanocortin Peptides to Treat Immune System Dysregulation
Palatin获得美国专利，使用黑色素皮质素多肽治疗免疫系统调节失调
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册